Overview

of Myo-inositol, Melatonin and Co-enzyme q10 on Ovarian Reserve

Status:
NOT_YET_RECRUITING
Trial end date:
2024-12-30
Target enrollment:
Participant gender:
Summary
To evaluate the role of Myo-inositol, melatonin and co-enzyme Q10 on ovarian reserve parameters and ICSI outcome in poor ovarian responder
Phase:
PHASE3
Details
Lead Sponsor:
Beni-Suef University
Treatments:
coenzyme Q10
Folic Acid
Inositol
Melatonin